Multiple Myeloma DREAM Challenge

The Multiple Myeloma DREAM Challenge aims to accelerate the development and evaluation of models for risk stratification of patients to improve therapeutic decision-making.

Multiple Myeloma DREAM Challenge

Multiple myeloma (MM) is a cancer of the plasma cells in the bone marrow, and its clinical course depends on a complex interplay of clinical traits and molecular characteristics of the plasma cells. Since risk-adapted therapy is becoming standard of care, there is an urgent need for a precise risk stratification model to assist in therapeutic decision-making. While progress has been made, there remains a significant opportunity to improve patient stratification to optimize treatment and to develop new therapies for high-risk patients. The MM DREAM Challenge aims to accelerate the development and evaluation of such risk models in multiple myeloma.


Other Assessments & Benchmarking research studies

ICGC-TCGA DREAM Somatic Mutation Calling – RNA Challenge

The ICGC-TCGA DREAM Somatic Mutation Calling - RNA Challenge is an international effort to improve standard methods for identifying cancer-associated rearrangements in RNA sequencing (RNA-seq) data.

Learn More

Multiple Myeloma DREAM Challenge

The Multiple Myeloma DREAM Challenge aims to accelerate the development and evaluation of models for risk stratification of patients to improve therapeutic decision-making.

Learn More

Digital Mammography DREAM Challenge

The Digital Mammography DREAM Challenge will attempt to improve the predictive accuracy of digital mammography for the early detection of breast cancer.

Learn More